Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)
Charlotte Both, Sascha Gerdes, Sreekanth Gattu, Yannick Allanore et al.
Journal
Drugs in R&D
Topics
Biosimilars and Bioanalytical Methods
article
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)
Charlotte Both, Sascha Gerdes, Sreekanth Gattu, Yannick Allanore, Sohaib Hachaichi, Hendrik Schulze‐Koops, Diamant Thaçi, Arthur Kavanaugh, Marco Matucci-Cerinic
article en
Abstract
No abstract available for this paper.
Publication Tag
Drugs in R&DVol. 25(2)
Institutions
Vita-Salute San Raffaele University (IT), Université Paris Cité (FR), University of California San Diego (US), Hexal (Germany) (DE), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), University Hospital Schleswig-Holstein (DE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Florence (IT), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)